Publicaciones en colaboración con investigadores/as de Centro de Investigación Médica Aplicada (9)

2022

  1. Trimethylamine N-oxide (TMAO) drives insulin resistance and cognitive deficiencies in a senescence accelerated mouse model

    Mechanisms of Ageing and Development, Vol. 204

2021

  1. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2017

  1. Aggregation of the inflammatory s100a8 precedes a? plaque formation in transgenic app mice: Positive feedback for s100a8 and a? productions

    Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 72, Núm. 3, pp. 319-328

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

  2. Chronic mild stress and imipramine treatment elicit opposite changes in behavior and in gene expression in the mouse prefrontal cortex

    Pharmacology Biochemistry and Behavior, Vol. 135, pp. 227-236

2012

  1. Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain

    Journal of Neuroscience Research, Vol. 90, Núm. 2, pp. 518-528

  2. The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation

    Neurobiology of Disease, Vol. 48, Núm. 3, pp. 290-298

2011

  1. Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease

    British Journal of Pharmacology, Vol. 164, Núm. 8, pp. 2029-2041

2010

  1. Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF

    Neurobiology of Disease, Vol. 38, Núm. 2, pp. 237-245